<DOC>
	<DOCNO>NCT03004326</DOCNO>
	<brief_summary>Multi-center observational study evaluate histopathology transcriptome cutaneous lesion patient several different type vasculitis .</brief_summary>
	<brief_title>Clinical Transcriptomics Systemic Vasculitis ( CUTIS )</brief_title>
	<detailed_description>This study employ multi-center approach evaluate cutaneous vasculitis across several form idiopathic vasculitis . Patients cutaneous manifestation vasculitis evaluate team primary vasculitis care provider Dermatologists order facilitate optimal selection patient sample lesion . A punch skin biopsy site active vasculitis source material histopathologic transcriptomic evaluation . The histopathology cutaneous vasculitis characterize use standardized approach .</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Polyarteritis Nodosa</mesh_term>
	<mesh_term>Churg-Strauss Syndrome</mesh_term>
	<mesh_term>Cryoglobulinemia</mesh_term>
	<criteria>Have cutaneous lesion ( purpuric macule , palpable purpura , retiform purpura , nodule , ulcer , urticarial ) believe related active vasculitis Have suspect confirm diagnosis : Cryoglobulinemic vasculitis ( CV ) Druginduced vasculitis Eosinophilic granulomatosis polyangiitis ( EGPA ) IgA vasculitis Isolated cutaneous vasculitis Granulomatosis polyangiitis ( GPA ) Microscopic polyangiitis ( MPA ) Polyarteritis nodosa ( PAN ) Urticarial vasculitis Be willing able provide write informed consent ( assent You less five year old Considered candidate biopsy high risk develop infection , bleeding , etc. , biopsy , doctor believe risk participate study outweigh potential benefit learn information biopsy You neutrophil count ( type white blood cell ) less 1500/mm3 , platelet count less 50,000/mm3 , hemoglobin le 7 g/dL You uncontrolled disease could prevent complete study procedure You active infection near potential biopsy site , poor circulation , bony prominence structure would increase risk complication participate study You pregnant nurse You able provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>DIV</keyword>
	<keyword>CSS</keyword>
	<keyword>EGPA</keyword>
	<keyword>HSP</keyword>
	<keyword>GPA</keyword>
	<keyword>MPA</keyword>
	<keyword>PAN</keyword>
	<keyword>Wegeners</keyword>
</DOC>